Accéder au contenu
Merck

Chimeric rat/human HER2 efficiently circumvents HER2 tolerance in cancer patients.

Clinical cancer research : an official journal of the American Association for Cancer Research (2014-03-29)
Sergio Occhipinti, Laura Sponton, Simona Rolla, Cristiana Caorsi, Anna Novarino, Michela Donadio, Sara Bustreo, Maria Antonietta Satolli, Carla Pecchioni, Cristina Marchini, Augusto Amici, Federica Cavallo, Paola Cappello, Daniele Pierobon, Francesco Novelli, Mirella Giovarelli
RÉSUMÉ

Despite the great success of HER2 vaccine strategies in animal models, effective clinical results have not yet been obtained. We studied the feasibility of using DNA coding for chimeric rat/human HER2 as a tool to break the unresponsiveness of T cells from patients with HER2-overexpressing tumors (HER2-CP). Dendritic cells (DCs) generated from patients with HER2-overexpressing breast (n = 28) and pancreatic (n = 16) cancer were transfected with DNA plasmids that express human HER2 or heterologous rat sequences in separate plasmids or as chimeric constructs encoding rat/human HER2 fusion proteins and used to activate autologous T cells. Activation was evaluated by IFN-γ ELISPOT assay, perforin expression, and ability to halt HER2+ tumor growth in vivo. Specific sustained proliferation and IFN-γ production by CD4 and CD8 T cells from HER2-CP was observed after stimulation with autologous DCs transfected with chimeric rat/human HER2 plasmids. Instead, T cells from healthy donors (n = 22) could be easily stimulated with autologous DCs transfected with any human, rat, or chimeric rat/human HER2 plasmid. Chimeric HER2-transfected DCs from HER2-CP were also able to induce a sustained T-cell response that significantly hindered the in vivo growth of HER2(+) tumors. The efficacy of chimeric plasmids in overcoming tumor-induced T-cell dysfunction relies on their ability to circumvent suppressor effects exerted by regulatory T cells (Treg) and/or interleukin (IL)-10 and TGF-β1. These results provide the proof of concept that chimeric rat/human HER2 plasmids can be used as effective vaccines for any HER2-CP with the advantage of being not limited to specific MHC. Clin Cancer Res; 20(11); 2910-21. ©2014 AACR.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Iodure de propidium, ≥94.0% (HPLC)
Sigma-Aldrich
Sodium chromate, 98%
Sigma-Aldrich
Iodure de propidium solution
Sigma-Aldrich
Iodure de propidium, ≥94% (HPLC)
Sigma-Aldrich
Human Decorin ELISA Kit, for serum, plasma, cell culture supernatant and urine
Sigma-Aldrich
Mouse Decorin ELISA Kit, for serum, plasma and cell culture supernatant